Access cutting-edge lung cancer treatment through this clinical trial at a research site in Ames. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Ames at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
The primary objective of this study is to compare the efficacy of ABP 234 with the pembrolizumab reference product (Keytruda®).
Sponsor: Amgen
Check if you qualify for this lung cancer clinical trial in Ames, IA
If you're searching for lung cancer treatment options in Ames, IA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Ames research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.